Browsing by Subject "C12N 7/00 (20130101)"
Now showing items 1-7 of 7
-
Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines
(U.S. Patent and Trademark Office, 2020-11-24)Highly antigenic yet safe vaccines against diseases caused by Paramyxoviridae viruses such as respiratory syncytial virus (RSV) are provided. The vaccines comprise attenuated Paramyxoviridae viruses with high antigenicity ... -
Immunogenic Compositions, Vaccines and Diagnostics Based on Canine Distemper Viruses Circulating in North American Dogs
(U.S. Patent and Trademark Office, 2014-02-11)Immunogenic compositions and broad-spectrum vaccines containing newly identified isolates of canine distemper virus (CDV) collected from a geographic area are provided. The newly identified isolates exhibit attributes of ... -
Isolation of a Virus Related to Canine Parvovirus-2 from a Raccoon
(U.S. Patent and Trademark Office, 2014-05-27)Vaccines preparations against canine parvovirus are provided. The vaccines include a novel canine parvovirus-2 isolated from a raccoon, and related nucleic acids and proteins. -
RSV vaccines and methods of production and use thereof
(U.S. Patent and Trademark Office, 2020-10-13)Recombinant, live, attenuated viruses of the Pneumoviridae family are disclosed that include a baculovirus GP64 envelope glycoprotein or variant or fragment thereof and a respiratory syncytial virus (RSV) F protein variant ... -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2012-07-24)Canine parvovirus vaccines and diagnostics and methods for their use are provided. -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2013-12-17)Canine parvovirus vaccines and diagnostics and methods for their use are provided. The vaccines are effective against emerging canine parvovirus variants. -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2012-09-04)Canine parvovirus vaccines and diagnostics and methods for their use are provided.